Avosentan

Avosentan (Ro 67-0565; SPP-301) 是一种有效的选择性内皮素受体 (ETA 受体) 拮抗剂。

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥1125.00

900.00

- +
10mg

￥1512.00

1210.00

- +
50mg

￥7012.00

5610.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci7052
CAS: 290815-26-8
别名: N-[6-甲氧基-5-(2-甲氧基苯氧基)-2-(4-吡啶基)-4-嘧啶基]-5-甲基吡啶-2-磺酰胺,Ro 67-0565; SPP-301
分子式: C23H21N5O5S
分子量: 479.51
纯度: >98%
溶解度: Soluble in DMSO
储存: Store at -20°C
库存: 现货

Background

Avosentan(Ro 67-0565; SPP-301) is a potent, selective endothelin receptor(ETA receptor) antagonist.IC50 value:Target: ETA receptor

参考文献:
[1]. Baltatu OC, Iliescu R, Zaugg CE, Reckelhoff JF, Louie P, Schumacher C, Campos LA.Antidiuretic effects of the endothelin receptor antagonist avosentan.Front Physiol. 2012;3:103.
[2]. Konieczka K, Meyer P, Schoetzau A, Neutzner A, Mozaffarieh M, Flammer J.Effect of avosentan (SPP-301) in porcine ciliary arteries.Curr Eye Res. 2011 Feb;36(2):118-24.
[3]. Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G; ASCEND Study Group.J Am Soc Nephrol. 2010 Mar;21(3):527-35.
[4]. Dieterle W, Hengelage T.Absolute bioavailability and pharmacokinetics of avosentan in man.Int J Clin Pharmacol Ther. 2009 Sep;47(9):587-94.
[5]. Effect of SPP 301, an Endothelin Antagonist, on Intraocular Pressure in Glaucomatous Monkey Eyes By Wang, Rong-Fang; Podos, Steven M.; Serle, Janet B.; Baltatu, Ovidiu C. From Current Eye Research (2011), 36(1), 41-46.